• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预防艾滋病发展的艾滋病毒疫苗接种数学模型。

A mathematical model of vaccination against HIV to prevent the development of AIDS.

作者信息

Nowak M A, McLean A R

机构信息

Department of Zoology, University of Oxford, U.K.

出版信息

Proc Biol Sci. 1991 Nov 22;246(1316):141-6. doi: 10.1098/rspb.1991.0136.

DOI:10.1098/rspb.1991.0136
PMID:1685238
Abstract

Vaccination and post-exposure immunization against the human immunodeficiency viruses (HIV-1 and HIV-2) faces the problem of the extensive genetic and antigenic variability of these viruses. This raises the question of what fraction of all possible antigen strains of the virus must be recognized by the immune response to a vaccine to prevent development of acquired immunodeficiency disease (AIDS). The success of a vaccine can depend on the variability of the target epitopes. The different HIV variants must be suppressed faster than new escape mutants can be produced. In this paper the antigenic variation of HIV during an individual infection is described by a stochastic process. The central assumption is that antigenic drift is important for the virus to survive immunological attack and to establish a persistent infection that leads to the development of AIDS after a long incubation period. The mathematical analysis reveals that the fraction of antigenic variants recognized by the immune response, that is induced by a successful immunogen, must exceed 1-1/R, where R is the diversification rate of the virus population. This means that if each HIV strain can produce, on average, five new escape mutants, then more than 80% of the possible variants must be covered by the immunogen. A generic result of the model is that, no matter how immunogenic a vaccine is, it will fail if it does not enhance immune attack against a sufficiently large fraction of strains. Furthermore, it is shown that the timing of the application of post-exposure immunization is important.

摘要

针对人类免疫缺陷病毒(HIV - 1和HIV - 2)的疫苗接种及暴露后免疫面临着这些病毒广泛的基因和抗原变异性问题。这就引出了一个问题:疫苗引发的免疫反应必须识别病毒所有可能抗原菌株中的多大比例,才能预防获得性免疫缺陷疾病(AIDS)的发展。疫苗的成功与否可能取决于靶抗原表位的变异性。必须比新的逃逸突变体产生得更快地抑制不同的HIV变体。本文通过一个随机过程描述了个体感染期间HIV的抗原变异。核心假设是抗原漂移对于病毒在免疫攻击下存活并建立持续感染至关重要,这种持续感染在长时间潜伏期后会导致AIDS的发展。数学分析表明,由成功的免疫原诱导的免疫反应所识别的抗原变体比例必须超过1 - 1/R,其中R是病毒群体的多样化率。这意味着,如果每个HIV毒株平均能产生五个新的逃逸突变体,那么免疫原必须覆盖超过80%的可能变体。该模型的一个普遍结果是,无论疫苗的免疫原性如何,如果它不能增强针对足够大部分毒株的免疫攻击,疫苗都会失败。此外,研究表明暴露后免疫接种的时机很重要。

相似文献

1
A mathematical model of vaccination against HIV to prevent the development of AIDS.一种用于预防艾滋病发展的艾滋病毒疫苗接种数学模型。
Proc Biol Sci. 1991 Nov 22;246(1316):141-6. doi: 10.1098/rspb.1991.0136.
2
Present status of vaccination against HIV-1 infection.
Int J Immunopharmacol. 1995 Feb;17(2):75-8. doi: 10.1016/0192-0561(94)00087-5.
3
Peptide immunogens designed to enhance immune responses against human immunodeficiency virus (HIV) mutant strains: a plausible means of preventing viral persistence.旨在增强针对人类免疫缺陷病毒(HIV)突变株免疫反应的肽免疫原:一种预防病毒持续存在的可行方法。
J Theor Biol. 2005 Mar 7;233(1):85-90. doi: 10.1016/j.jtbi.2004.09.008. Epub 2004 Nov 6.
4
Modeling AIDS vaccines: the cellular level.模拟艾滋病疫苗:细胞层面。
Mem Inst Oswaldo Cruz. 1992 Jan-Mar;87(1):103-13. doi: 10.1590/s0074-02761992000100017.
5
Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.HIV-1的基因和表型变异:对艾滋病发病机制及疫苗接种的影响
Chem Immunol. 1993;56:1-33.
6
The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease.人类免疫缺陷病毒1型准种的进化动力学与免疫缺陷疾病的发展
AIDS. 1990 Nov;4(11):1095-103. doi: 10.1097/00002030-199011000-00007.
7
Cross-clade immune responses after immunization with a whole-killed gp120-depleted human immunodeficiency virus type-1 immunogen in incomplete Freund's adjuvant (HIV-1 immunogen, REMUNE) in human immunodeficiency virus type-1 seropositive subjects.
Viral Immunol. 1997;10(4):221-8. doi: 10.1089/vim.1997.10.221.
8
Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.在人免疫缺陷病毒1型/鼠白血病病毒假型攻击模型中评估联合DNA和佐剂蛋白疫苗接种的免疫原性和效力。
Vaccine. 2007 Mar 1;25(11):2145-54. doi: 10.1016/j.vaccine.2006.10.057. Epub 2006 Nov 13.
9
Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).用两种不同减毒疫苗对猕猴进行序贯免疫可诱导长期的病毒特异性免疫反应,并对由异源猴免疫缺陷病毒(SHIV(89.6)P)引起的艾滋病提供保护。
Virology. 2001 Jan 5;279(1):241-56. doi: 10.1006/viro.2000.0695.
10
HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID mice.HIV-1 p17合成肽疫苗HGP-30:在人体受试者中诱导免疫反应及在严重联合免疫缺陷小鼠中抵御HIV攻击的初步保护证据
Cell Mol Biol (Noisy-le-grand). 1995 May;41(3):401-7.

引用本文的文献

1
HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.HIV 群体水平上的适应性可以迅速降低部分有效疫苗的效果。
Vaccine. 2018 Jan 25;36(4):514-520. doi: 10.1016/j.vaccine.2017.12.004. Epub 2017 Dec 11.
2
Dynamic model predicting overweight, obesity, and extreme obesity prevalence trends.动态模型预测超重、肥胖和极度肥胖流行趋势。
Obesity (Silver Spring). 2014 Feb;22(2):590-7. doi: 10.1002/oby.20520. Epub 2013 Sep 18.
3
Overcoming viral escape with vaccines that generate and display antigen diversity in vivo.
通过在体内产生并展示抗原多样性的疫苗来克服病毒逃逸。
Virol J. 2007 Nov 22;4:125. doi: 10.1186/1743-422X-4-125.
4
Intra-host competition between nef-defective escape mutants and wild-type human immunodeficiency virus type 1.Nef缺陷型逃逸突变体与野生型1型人类免疫缺陷病毒之间的宿主内竞争
Proc Biol Sci. 2000 Jan 22;267(1439):183-9. doi: 10.1098/rspb.2000.0985.